Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

Molecular Biology Reports

Volumn 40, Issue 3, 2013, Pages 2145-2147

  Mȩdrek, Krzysztof ^a   Magnowski, Piotr ^b   Masojć, Bartłomiej ^a   Chudecka Głaz, Anita ^a   Torbe, Bogdan ^c   Menkiszak, Janusz ^a   Spaczyński, Marek ^b   Gronwald, Jacek ^a   Lubiński, Jan ^a   Górski, Bohdan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Westpomeranian Oncology Centre   (Poland)

Author keywords

Genotyping; Ovarian cancer; Polish population; SNP; TP53; WRAP53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLAND; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; TUMOR SUPPRESSOR GENE; WRAP 53 GENE;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; POLAND; RISK; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878403466     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2273-9     Document Type: Article

References (17)

1. OMIM 2012. http://www.ncbi.nlm.nih.gov/omim/. [Online]
2. Noma M et al (2004) Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Lett 210(2):197-203
3. Zhu ZZ et al (2007) Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol 2007(37):385-390
4. Koushik A et al (2006) p53Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 2006(119):1863-1868
5. Kalemi TG et al (2005) The association of p53 mutations and p53 codon 72, Her2 codon 655 and MHTFR C677T polymorphism with breast cancer in Northern Greece. Cancer Lett 2005(222):57-65
6. Buyru T, Tigli H, Dalay N (2003) p53 codon 72 polymorphism in breast cancer. Oncol Rep 2003(10):711-724
7. Damin AP et al (2006) Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk. Cancer Detect Prev 2006(30):523-529
8. Ohayon T et al (2005) The R72P p53 mutation is associated with familial breast cancer risk in Jewish women. Br J Cancer 2005(92):1144-1148
9. Agorastos T et al (2004) P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur J Cancer Prev 13(4):277-280
10. Schildkraut J et al (2009) Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 69(6):2349-2357
11. Schildkraut JM et al (2010) Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. PLoS ONE 5(4):e10061
12. Mahmoudi S et al (2009) Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 33(462-471):2009
13. Farnebo M (2009) Wrap53, a novel regulator of p53. Cell Cycle 8(15):2343-2346
14. Saldaña-Meyer R, Recillas-Targa F (2011) Transcriptional and epigenetic regulation of the p53 tumor suppressor gene. Epigenetics 6(9):1068-1077
15. Garcia-Closas M et al (2007) Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer 121(11):2532-2538
16. Mahmoudi S et al (2011) WRAP53 promotes cancer cell survival and is a potential target for cancer therapy. Cell Death Dis 2:e114
17. Lahiri DK, Schnabel B (1993) DNA isolation by rapid method from human blood samples:effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 1993(31):321-328